<cite id="thdh1"></cite><cite id="thdh1"><noframes id="thdh1">
<i id="thdh1"></i> <cite id="thdh1"><span id="thdh1"><cite id="thdh1"></cite></span></cite>
<ins id="thdh1"><noframes id="thdh1"><cite id="thdh1"></cite><cite id="thdh1"></cite><ins id="thdh1"></ins>
<cite id="thdh1"><span id="thdh1"><cite id="thdh1"></cite></span></cite>
<ins id="thdh1"></ins>
<cite id="thdh1"><noframes id="thdh1"><cite id="thdh1"></cite>
<ins id="thdh1"></ins>
中肽生化目录肽版块全新呈现,致力于打造全球最全面的多肽供应平台!我们专业的学术团队将时刻追踪最新最热的研究动向,帮助您发现实际需求,并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表,为您最大限度地节约科研时间,敬请广大客户朋友关注!
NATR-004B
Urodilatin (95-126)
Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Cys11&Cys27 bridge)
Size:1.0mg
P1(RMB):1195
MW:3506
One letter sequence:TAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY(Cys11&Cys27 bridge)
Molecular Formula:C145H234N52O44S3
Description:Urodilatin (95-126) originally extracted from human urine that corresponds to the family of natriuretic-vasorelaxant peptides found earlier in heart atria. Infusion of this peptide is found to represent a concept for the treatment of therapy-resistant acute renal failure after liver transplantion. The use of NATR-004 is protected by patents.
Literature Reference:P. Schultz-Knappe et al., Klin. Wochenschr., 66, 752 (1988)
Cas:[115966-23-9]
国产精品女a片爽爽免费视频,国产精品任我爽爆在线播放,国产精品特级露脸av毛片